Pegylated recombinant human arginase (BCT-100)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pegylated recombinant human arginase (BCT-100), covering 2022-09-02 to 2022-09-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100) [Phase 1, Phase 2]